Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Mayne

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer CellsJian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
Science Signaling|May 26, 2016
Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissuesZeynep Madak-Erdogan, Sung Hoon Kim, Ping Gong, et al.
Elife|February 3, 2016
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformationSean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer CellsJian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
Science Signaling|May 26, 2016
Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissuesZeynep Madak-Erdogan, Sung Hoon Kim, Ping Gong, et al.
Elife|February 3, 2016
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformationSean W Fanning, Christopher G Mayne, Venkatasubramanian Dharmarajan, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
Pageof 4